Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ASSOCIATION OF COMMUNITY CANCER CENTERS 1 PERSONALIZING CARE FOR PATIENTS OF ALL BACKGROUNDS ASSOCIATION OF COMMUNITY CANCER CENTERS Importance of Addressing Patient Identity Patients are people first—individuals with varying back- grounds, circumstances, and life experiences—therefore next-level cancer care should consider the unique needs and preferences of patients …
Targeted Oncology’s Register Today targetedonc.com/events Seating is limited, and registration will close when capacity is reached. Reserve your seat today! Stay informed on the latest research data in an informal, case-based discussion after spending some time networking with peers while enjoying breakfast and refreshments CONNECT WITH THE COMMUNITY You choose the topic that …
September 16, 2023
The Wisconsin Association of Hematology and Oncology (WAHO) and Wisconsin Oncology Network (WON) are once again joining forces to host the WAHO 2023 Annual Conference. This collaborative forum will explore exciting clinical advances in cancer treatment and spark discussions around some of the most critical topics in oncology. Reserve your spot to discover new clinical trends, expand your professional …
ASCO / ESMO updates [H/N Current Landscape] Moises Harari-Turquie, MD Assistant Professor – UNMCCC 09/16/2023 H/N Current Landscape • No disclosures Index • Epidemiology, risk factors and pathways • Adjuvant treatment • Recurrent and metastatic disease • Neoadjuvant / Induction chemotherapy • New therapeutic options • Conclusions Objectives • Discussion …
PowerPoint Presentation HPV-Positive HNSCC: Emerging Biomarkers for Predicting HPV+ HNSCCs and Potential Use of FDA-Approved MEK Inhibitors for Treating HPV Precancers and De-Intensifying HPV-Cancer Therapeutics Michelle A. Ozbun, Ph.D. The Maralyn S. Budke Endowed Professor of Viral Oncology Departments of Molecular Genetics & Microbiology, Obstetrics & Gynecology The University …
Slide 1 Questions for the pathologist: 1. Why so much trouble making this diagnosis? 2. What is p16? Is it/how is it important? HPV E7 HR-HPV in-situ hybridization HPV E7 1. Non-oropharynx primary: don’t perform HPV testing 2. Oropharynx location, lymph node level II or III, morphology …
1 OFFICERS President Olalekan Ajayi, PharmD, MBA Highlands Oncology Group Springdale, Arkansas President-Elect Nadine J. Barrett, PhD, MA, MS Duke Cancer Institute Durham, North Carolina Treasurer Douglas B. Flora, MD, LSSBB St. Elizabeth Cancer Edgewood, Kentucky Secretary Una Hopkins, RN, …
1 OFFICERS President Olalekan Ajayi, PharmD, MBA Highlands Oncology Group Springdale, Arkansas President-Elect Nadine J. Barrett, PhD, MA, MS Duke Cancer Institute Durham, North Carolina Treasurer Douglas B. Flora, MD, LSSBB St. Elizabeth Cancer Edgewood, Kentucky Secretary Una Hopkins, RN, …
In 2023, ACCC hosted a series of interactive sessions at the ACCC 49th Annual Meeting and Cancer Center Business Summit to collect insights and solutions into 8 key areas.
Dental Management of the Oncology Patient Jessica Pharar, DMD Pharar Foundation Financial Disclosures  No financial disclosures to report Pre-treatment How much dentistry do we do before the patient starts their care? Modulated by patient’s prognosis and health status Good quality, clear communication with oncology care team is essential …
Microsoft PowerPoint - Trends in HPV-Related Cancers in New Mexico 16Sep2023 Epidemiology and Prevention of Head & Neck Cancer Charles Wiggins, Ph.D. Director and Principal Investigator New Mexico Tumor Registry New Mexico Society of Clinical Oncology Saturday – September 15, 2023 Outline • Public Health Surveillance for Cancer • New Mexico Tumor Registry • …
Nutritional Interventions for Head and Neck Cancer patients Nutrition for Head & Neck Cancer Patients Teresa Miller, MS, RDN, LDN tmiller@agilixhealth.com Nutritional Challenges for HNC Patients Radiotherapy • Dysgeusia & ageusia • Xerostomia • Mucositis • Odynophagia • Dysphagia • Thrush • Increased or thick secretions • Anorexia Chemotherapy • Dysgeusia & ageusia …
PowerPoint Presentation Case 1: Surgeon’s Two Cents ANDREW COWAN, MD, PHD NMSCO ANNUAL CONFERENCE, 9/15/23 Tonsil?  2.8 x 2.6 cm mass in the left pharyngeal space [assume oropharynx]  The oropharynx is bounded anteriorly by the oral cavity, superiorly by the nasopharynx, and inferiorly by the larynx and the hypopharynx. Nasopharynx  Bounded anteriorly by …
Speech Language Pathologists Speech Language Pathologists Contribution for Head and Neck Cancer Patients What do Speech Language Pathologists specialize in?  Speech  Language  Swallowing  Cognitive communication  Social communication  Auditory processing  Fluency  Voice disorders  AAC (Alternative and augmentative communication)  Disorders we might see in our …
On September 11, 2023, ACCC submitted comment letters to the Centers for Medicare and Medicaid Services (CMS) on the proposed physician fee schedule (PFS) and hospital outpatient prospective payment system (OPPS) regulations. Among other topics, ACCC supported the proposal for Medicare reimbursement for principal illness navigation (PIN) services to assist those with serious illnesses such as …
SCOS ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TxSCO 9.23 Attendee Roster as of 9.14.xlsx TxSCO 2023 Annual Conference September 23, 2023 Hyatt Regency Frisco Dallas Frisco, TX Attendee Roster First Name Last Name Title Account Name Ashley Barlow PharmD AbbVie Inc. Jigar Trivedi Medical Science Liaison (Hematology) AbbVie Inc. Kristin Evans Account Executive AbbVie Inc. Mary Peterson Nurse Practitioner/Oncology Clinical …
NCOA ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TACOS ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …
TxSCO ONCOLOGY DRUG NEWSLETTER S E P T E M B E R 2 0 2 3 This content is being shared with permission from MJH Life Sciences. All content of Targeted Oncology is independently created and owned by MJH Life Sciences. FDA APPROVALS Blinatumomab (Blincyto) The FDA awarded full approval to blinatumomab (Blincyto) for the treatment of adults and pediatric patients with CD19-positive B-cell …